![]() | ![]() |
Formats:
|
||||||||||||||||||
Microtubule Plus-End-Tracking Proteins Target Gap Junctions Directly from the Cell Interior to Adherens Junctions 1 Cardiovascular Research Institute and Department of Medicine, University of California, San Francisco, CA 94143, 2 Graduate Group in Biophysics, University of California, San Francisco, CA 94143, 3 Departments of Psychiatry and Cellular & Molecular Pharmacology, University of California, San Francisco, CA 94143, 4 Howard Hughes Medical Institute and Departments of Physiology and Biochemistry, University of California, San Francisco, CA 94143, USA *Correspondence: Email: lily.jan/at/ucsf.edu 5These authors contributed equally to this work. SUMMARY Gap junctions are intercellular channels that connect the cytoplasms of adjacent cells. For gap junctions to properly control organ formation and electrical synchronization in the heart and the brain, connexin-based hemichannels must be correctly targeted to cell-cell borders. While it is generally accepted that gap junctions form via lateral diffusion of hemichannels following microtubule-mediated delivery to the plasma membrane, we provide evidence for direct targeting of hemichannels to cell-cell junctions through a pathway that is dependent on microtubules; through the adherens-junction proteins N-cadherin and β-catenin; through the microtubule plus-end-tracking protein (+TIP) EB1; and through its interacting protein p150(Glued). Based on live cell microscopy that includes fluorescence recovery after photobleaching (FRAP), total internal reflection fluorescence (TIRF), deconvolution, and siRNA knockdown, we propose that preferential tethering of microtubule plus ends at the adherens junction promotes delivery of connexin hemichannels directly to the cell-cell border. These findings support an unanticipated mechanism for protein delivery to points of cell-cell contact. INTRODUCTION Gap junctions, which are formed by the serial coupling of hemichannels of adjacent cells, allow direct sharing of ions and small cytoplasmic molecules. Each hemichannel is a hexamer of connexin, and the most common isoform is Connexin43 (Cx43). Gap junctions reside at cell-cell borders, where their density is of critical importance. In the heart, for example, gap junctions are concentrated at the intercalated disc (ID) that joins the ends of cardiomyocytes, and this is where they ensure propagation of action potentials (Gros and Jongsma, 1996; Shaw and Rudy, 1997). Altered Cx43 gap junction distribution following cardiac ischemia contributes to malignant ischemic arrhythmias (Kaprielian et al., 1998; Peters et al., 1997; Shaw and Rudy, 1997). Preventing or reversing this process offers a strategy to repair damaged heart (Abraham et al., 2005; Reinecke et al., 2004). Understanding the molecular mechanism of gap junction localization at the cell-cell border, therefore, is important not only for addressing the basic cell biological question of gap junction formation but also for developing treatments for life-threatening diseases. A model for gap junction formation has emerged from biochemical and cell biological studies over the past decade. The half-life of Cx43 is between 1 and 3 hr (Beardslee et al., 1998; Laird et al., 1991), which indicates that gap junction trafficking is a dynamic process. Gap junction hemichannels that are packaged in vesicles emerge from the Golgi, reach the cortical membrane via microtubules, which have insertion sites all over the cell surface (Jordan et al., 1999; Lauf et al., 2002), and form clusters of gap junctions known as plaques at cell-cell borders. FRAP studies show that connexin hemichannels can float freely within the cortical membrane (Lauf et al., 2002). Over a time course of tens of minutes or hours, newer hemichannels are evident first at the plaque perimeter and later on throughout the plaque (Gaietta et al., 2002; Lauf et al., 2002), which leads to this commonly held view of gap junction plaque formation: after their microtubule-mediated delivery, hemichannels diffuse laterally within the membrane to cell-cell border regions. In this model, hemichannels that coalesce at the periphery of the plaques then move inwards, and those reaching the center of the plaque become internalized for degradation as annular gap junctions (Laird, 2005; Segretain and Falk, 2004). The current model is the simplest scenario that could account for the experiments reported thus far, but it does not explain how plaques occur at specific locations of the cell membrane. While junctional proteins such as ZO-1 may retain connexins (Giepmans and Moolenaar, 1998), few other connexin-binding proteins have been identified. In multiple tissues, gap junctions colocalize with adherens junctions (AJs) formed by cadherins. At the cardiac ID, the AJs are assembled prior to the establishment of a Cx43 gap junction plaque (Angst et al., 1997). Notably, mislocalized Cx43 plaques in ischemic myocardium are associated with similarly mislocalized AJs (Matsushita et al., 1999). Indeed, transfection of E-cadherin into gap junction-incompetent cells allows the transfected cells to form functional gap junctions (Mege et al., 1988). Moreover, N-cadherin knockout mice cannot form gap junctions (Luo and Radice, 2003), and conditional knockout of N-cadherin in the heart causes poor expression and mislocalization of gap junctions, thus leading to arrhythmogenic death (Li et al., 2005). Since Cx43-laden microtubules must interact with the plasma membrane to deliver the hemichannels and because cadherin-mediated signaling is implicated in microtubule regulation (Jamora and Fuchs, 2002), we wondered whether plaque formation involves microtubule interaction with the AJ. We looked into the possible involvement of the microtubule plus-end-tracking proteins (+TIPs) because they control microtubule dynamics and could be captured by membrane-associated proteins (Akhmanova and Hoogenraad, 2005; Mimori-Kiyosue et al., 2005). Among the +TIPs, the dimeric EB1 associates directly with the plus ends of microtubules and has dual binding sites for a number of proteins, including p150(Glued) (Berrueta et al., 1999), which is a component of the dynein/dynactin complex. The dynein/dynactin complex, in turn, can tether microtubules at AJs (Chausovsky et al., 2000; Ligon et al., 2001). In this study, we analyzed plaques formed by fluorescently tagged Cx43 in HeLa cells that do not express endogenous Cx43. Within a few minutes following the photobleaching of a plaque and its surrounding area in our FRAP studies, there was rapid replenishment of fluorescent Cx43 within the plaque but not in the bleached surrounding area. The recovery was sensitive to reagents that alter microtubule dynamics. Time lapse imaging of live cells expressing fluorescently tagged EB1 and Cx43 further showed that microtubule plus ends approached the plaque more frequently than they approached the rest of the cortical membrane and that they remained at the plaque for longer periods of time. Moreover, gap junction plaque formation was disrupted by siRNA knockdown of EB1, of its binding partner p150(Glued), and of the AJ protein β-catenin. It was further disrupted by the application of peptides that compromise homophilic cadherin interactions at the AJ. In addition, TIRF microscopy showed enhanced EB1 interaction and Cx43 vesicle delivery to the cell surface that rested on coverslips coated with cadherin extracellular domains. Thus, mammalian cells use +TIPs for targeted delivery of Cx43 to form gap junction plaques that are spatially coincident with AJs; this mechanism could restrict intercellular communication to cells of the same tissue type. RESULTS Microtubules Extend Directly to Gap Junction Plaques at the Cell-Cell Border In isolated HeLa cells transiently transfected with a construct containing Cx43 tagged with yellow fluorescent protein (Cx43-YFP), Cx43-YFP was concentrated in the perinuclear Golgi. The protein then translocates to the cell-cell border when two cells came into contact. Imaging isolated cells with low levels of Cx43-YFP expression with long exposure times indicated that Cx43-YFP is localized to microtubules (Figure 1A
Microtubules Allow Rapid Connexin Delivery to Gap Junction Plaques Next, in FRAP studies we used a confocal microscope to follow Cx43-YFP dynamics in live HeLa cells with or without treatments that alter microtubule dynamics. Entire plaques and their surrounding areas were subjected to fluorescence photobleaching, and the recovery of fluorescence was monitored every 20 s for 5 min, revealing rapid repopulation of the plaque in its original geometry. Plaque reappearance was inhibited by 100 μM nocodazole, which depolymerizes microtubules, and 10 μM Taxol, which stabilizes microtubules but prevents growth at the plus end (Morrison et al., 1998; Figure 2
After bleaching in the horizontal XY plane, we recorded, depending on plaque geometries, in the horizontal plane for horizontally aligned plaques (data not shown) and in the vertical plane for vertically aligned plaques (Figure 2A The efficiency of plaque formation was quantified by allowing HeLa cells transfected with Cx43-YFP to form plaques over 18–24 hr prior to the nocodazole (100 μM, 30 min) or Taxol (10 μM, 2 hr) treatment and then the effect of these reagents on isolated pairs of cells expressing Cx43-YFP was assessed (Figure 3A
Preferential and Prolonged Association of the Microtubule Plus Ends with Plaques at the Cell-Cell Border To test whether microtubule plus ends preferentially interact with the cortical membrane in the vicinity of connexin plaques, we cotransfected HeLa cells with Cx43-RFP and fluorescently tagged EB1, which is a marker for rapidly growing microtubule plus ends (Figure 4A
Since imaging with widefield epifluorescence involves collapsing the depth of a three-dimensional structure into a plane, we used TIRF microscopy that limits the imaging depth to within 50–100 nm of the coverslip and examined cells that had been transfected with EB1-GFP and plated on coverslips coated with the extracellular domain of N-cadherin, thus allowing homophilic N-cadherin-N-cadherin contacts to form between the cell and the coverslip. Control coverslips were created with IgG. There was a much greater density of EB1 comets in the immediate vicinity of the plasma membrane and a longer EB1-cell membrane interaction in cells plated on coverslips coated with cadherin extracellular domains (Figures 4D Cx43 Vesicles Are Delivered Directly to AJs-Associated Membrane For direct visualization of vesicles being targeted for fusion with the cell membrane, we again used TIRF microscopy and monitored Cx43-YFP in cells plated on coverslips coated with either the extracellular domain of N-cadherin (Figures 5A and 5B
With TIRF microscopy to capture Cx43-YFP signals that originated only from membrane and submembrane regions, we analyzed individual Cx43 vesicle movements in the central square of the image (Figures 5A and 5C The vesicles of cells contacting the extracellular domain of N-cadherin were notable for a short prefusion path length (indicating directed delivery) and a high incidence of fusion (Figures 5A, 5B, and 5E In our TIRF imaging, there were rare occasions where microtubule orientation made it possible to observe a dynamic sequence in which several connexin vesicles apparently moved progressively toward the membrane just above the cadherin extracellular domains along a microtubule and fused with the membrane, thus causing a plaque at the membrane to grow in size (Movie S4). Subsequent immunofluorescence labeling of microtubules revealed their presence along the tracks for Cx43 vesicle movements. Consistent with membrane distribution of Cx43 being a function of directed delivery, the membrane patch with lowest overall Cx43 density corresponds to the regions with lowest microtubule density (middle panel, Movie S4). In addition, the computed vesicle velocity along the track, 1.8 ± 0.2 μm/s (n = 3 vesicles), is within the range of kinesin-based transport along microtubules (Hirokawa et al., 1998), which is consistent with the notion of microtubule-based Cx43 delivery directly into a growing gap junction plaque. EB1 siRNA Knockdown Disrupts Gap Junction Plaque Formation Next, we asked whether Cx43 plaque formation requires specific proteins that interact with the microtubule plus ends. Because Taxol can dissociate EB1 from microtubule plus ends (Morrison et al., 1998) and because EB1 appears to be involved in microtubule tethering (Figure 4
EB1-Interacting Protein p150(Glued) and β-Catenin Are Required for Cx43 Delivery to the Plaque The cadherin-based AJ is a highly efficient “glue” that binds cells together and may also regulate the microtubule cytoskeleton (Chausovsky et al., 2000; Waterman-Storer et al., 2000). Moreover, β-catenin, which is the cytoplasmic binding partner of cadherin, binds dynein (Ligon et al., 2001). The dynein/dynactin complex is a potential cortical anchor of microtubules (Fuchs and Karakesisoglou, 2001) since p150(Glued) in the dynactin complex has a binding domain for EB1 (Askham et al., 2002; Hayashi et al., 2005). Therefore, we tested for the involvement of p150(Glued) and β-catenin in forming gap junction plaques. Compared to HeLa cells expressing Cx43-YFP, with p150(Glued) in a cytoplasmic pool and at the cell-cell border near the plaques formed by Cx43-YFP, siRNA knockdown of p150(Glued) greatly decreased Cx43-YFP accumulation at the cortical membrane of the cell-cell border (Figures 6A If p150(Glued) connects the microtubule plus end to the AJ, β-catenin likely constitutes part of the cortical anchor, given that both β-catenin and the p150(Glued)-containing dynactin complex bind dynein. Indeed, immunocytochemistry of HeLa cells transfected with Cx43-YFP, with or without coexpression of β-catenin siRNA (Figure 6B We then examined the distribution of endogenous p150(Glued), β-catenin, and Cx43 in adult ventricular cardiomyocytes and found that they colocalize at the IDs. Colocalization of cardiac Cx43 and β-catenin (Figure 6D Homophilic Cadherin Interactions Are Required for Plaque Formation We next asked whether plaque formation also depends on cadherin. The extracellular domain of cadherin engages in homophilic interactions with cadherin from adjoining cells while the cytoplasmc domain of cadherin binds β-catenin. In order to test if functional N-cadherin on the cell membrane contributes to the formation of gap junction plaques, we applied a peptide that blocks homophilic intercellular N-cadherin interactions (Frenzel and Johnson, 1996) to HeLa cells already transfected with Cx43-YFP and adherent on coverslips. This treatment disrupted most cell-cell contacts, although isolated cell pairs could still be found (Figure 7A
DISCUSSION Microtubules Deliver Gap Junction Proteins Directly to Plaques at Cell-Cell Border Although microtubules are uniformly laden with connexin (Figure 1A If microtubules deliver Cx43 directly to the plaques, fluorescent Cx43 would repopulate bleached plaques with a distribution that mimics the prebleach plaque morphology rather than appearing first at the plaque perimeter. Indeed, our FRAP studies revealed a fast repopulation (recovery half-time of 2.8 min) that restored the original plaque morphology (Figure 2 How might our findings be reconciled with experiments that led to the lateral diffusion model of gap junction plaque formation? Previous studies have documented fusion between Cx43-containing vesicles and the plasma membrane of isolated cells as well as the presence and mobility of tagged Cx43 on the nonjunctional surface of HeLa cells (Jordan et al., 1999; Lauf et al., 2002). However, gap junction delivery to the plasma membrane depends not only on the potential for Cx43 hemichannels to arrive at non-contact regions (Jordan et al., 1999; Lauf et al., 2002) but also on the relative frequency of microtubule approaches to the cell-cell border versus other regions of the plasma membrane (Figure 4 Plaque repopulation has also been investigated using both FRAP and successive labeling of tetracysteine-tagged Cx43 with different fluorophores (Gaietta et al., 2002; Lauf et al., 2002). In the FRAP studies, 30 min to several hours after bleaching a portion of the plaque, YFP-tagged Cx43 was observed to accumulate at plaque edges (Lauf et al., 2002). The time resolution and the low fluorescence sensitivity necessitated by the imaging of the remaining unbleached plaque in this study would have precluded the detection of rapid plaque repopulation within a few minutes (Figure 2 We are not aware of a report that directly shows tagged Cx43 from nonborder regions of the cell membrane reaching an existing plaque, though this type of lateral diffusion probably accounts for the residual recovery that occurred when photobleaching followed nocodazole treatment in this and previous studies (Lauf et al., 2002; Thomas et al., 2005). In our FRAP studies, we bleached the entire plaque and observed repopulation at 20 s intervals, which revealed a rapid, microtubule-dependent repopulation of the original plaque (Figure 2 Microtubule +TIP Involvement in Gap Junction Plaque Formation Our FRAP studies revealed that nocodazole and Taxol both cause disruption of the fast repopulation of Cx43 plaques (Figure 2 How might the plus end-binding protein EB1 facilitate connexin delivery? The C terminus of EB1 binds the p150(Glued) subunit of the dynein/dynactin complex (Askham et al., 2002; Hayashi et al., 2005). Moreover, dynein/dynactin localizes with AJs at cell-cell contact points through direct binding with β-catenin (Ligon et al., 2001). In this manner, dynein/dynactin may serve as an anchor for microtubules at the AJ. We found that knockdown of p150(Glued) or β-catenin disrupts the formation of gap junction plaques (Figure 6 Implications for Developmental Biology and Cancer The proposed model for connexin trafficking suggests a mechanism for membrane protein localization at specific regions of the plasma membrane, which is a pathway of particular interest in developmental biology. Based on preferential adhesion between cells expressing the same cadherin type(s) or similar cadherin levels, cadherin-cadherin interactions affect cell sorting during tissue development (Wheelock and Johnson, 2003). Our findings suggest that connexin reaches the AJ via direct, microtubule-mediated delivery so that gap junctions may form preferentially between cell types that express the same type of cadherin. Mutations in Cx43 are associated with deafness, cataracts, germ cell development defects, oculodentodigital dysplasia, and cardiac outflow abnormalities (Wei et al., 2004). It would be interesting to explore the potential involvement of microtubule-mediated Cx43 delivery to AJs in these developmental processes and pathological conditions. Cancer cells tend to lose gap junction communication that is normally maintained between nonmalignant cells and, once they invade other tissues, generally form gap junctions only with other cancer cells. Just as loss of E-cadherin or upregulation of N-cadherin can lead to tumor invasiveness (Mareel and Leroy, 2003), both gain of and loss of connexin expression are associated with cancers. Cx43 expression is downregulated in a variety of cancers, including prostate, lung, bladder, and cervical cancers, as well as in gliomas and melanomas (Mesnil, 2002). Like Cx43, Cx26 targeting in HeLa cells was also compromised by siRNA knockdown of EB1 (Figure S12). Reduced gap junction coupling may help cells complete malignant transformation by limiting the spread of Ca2+-mediated apoptosis (Krutovskikh, 2002), while overexpression of connexins may lead to increased invasiveness of human glioblastomas (Oliveira et al., 2005). At present, there are few data linking cadherin to connexins in malignant cells. Testing for a correlation between targeting of connexins and cadherin-based AJs may be a first step toward developing new strategies to limit tumor growth and metastasis. Implications for Channel Trafficking and Cardiac Disease Cardiac excitation is an iterative process whereby inward current depolarizes the plasma membrane of a cardiomyocyte and initiates an action potential, which, in turn, drives a depolarizing current that spreads to adjacent cardiomyocytes through gap junctions. The flow of current for proper cardiac action potential propagation requires that electrical coupling through gap junctions be both robust and oriented along the long axis of cardiac fibers. Decreased or disorganized gap junction coupling due to myocardial ischemia leads to ventricular arrhythmias of sudden cardiac death and contributes to the pathogenesis of congestive heart failure. In addition, disorganization of gap junctions in ischemic myocardium is preceded by disorganized AJs (Matsushita et al., 1999). Our model for +TIPs-mediated gap junction trafficking suggests that AJ disruption contributes directly to the rearrangement of gap junction distribution. Furthermore, we provide a mechanism for gap junction localization that will likely apply to the subcellular targeting of other membrane proteins. EXPERIMENTAL PROCEDURES Details of standard technique, antibodies used, sequences, and nonessential imaging are in Supplemental Experimental Procedures. Cell Culture, Immunocytochemistry, and siRNA Knockdown HeLa and rat hepatic epithelial cells (WB-F344, which express endogenous Cx43) were cultured in standard mammalian cell conditions. FuGene 6 (Roche) was used for all cDNA tranfections. For immunocytochemistry, cells were cultured on 12 mm coverslips (Warner Instrument Corp.) that were precoated with bovine fibronectin (50 μg/ml). Taxol (10 μM) and nocodazole (100 μM; Sigma-Aldrich) were applied for 2 hr prior to fixation unless otherwise specified. N-cadherin peptide N-Ac-INPISGQ-NH2 (Williams et al., 2000; 10 mM; Anaspec, San Jose, CA) was applied shortly after transfection. Cells were fixed with methanol (−20°C) for 5 min. For siRNA knockdown, cells were transfected with siRNA (all RNA from Dharmacon, Lafayette, CO) at a final concentration of 100 nM using Lipofectamine RNAiMAX Reagent (Invitrogen, Carlsbad, CA). For cells transfected with both cDNA and siRNA, siRNA transfection occurred 24 hr prior to cDNA transfection. Quantification of Cx43 Plaque at Cell-Cell Border in Fixed Cells Cx43-YFP signal in isolated cell pairs was collected for a fixed exposure time. Cell borders were identified by double staining with N-cadherin, and the percentage of Cx43-YFP plaque was calculated by dividing the number of pixels with intensity greater than a preset intensity threshold by the number of pixels defining the border. Statistical significance was tested by one-tailed Student’s t test. Coimmunoprecipitation of EB1 with Cx43-YFP in HeLa Cells HeLa cells were transfected with Cx43-YFP, harvested, lysed, and exposed to agarose beads that had been pretreated with anti-EGFP antibody. Material bound to washed beads was eluted, boiled, separated, and probed with anti-EB1 antibody. FRAP and Widefield Imaging of Microtubules/EB1 FRAP studies were performed on HeLa cells transfected with Cx43-YFP using a Zeiss LSM confocal microscope with a 63× objective. Sampling rate was 20 s per time point, and bleach time was 40 s at high laser intensity. Widefield imaging was performed on HeLa cells that had been cotransfected with Cx43-mRFP and either GFP-tubulin (Clontech) or GFP-EB1. A Nikon TE2000-U inverted fluorescence microscope was used with a Photometrics Coolsnap HQ CCD camera. Stacks for deconvolution were obtained with 100 nm spacing, and deconvolution was performed using Autoquant software. Statistical significance was evaluated by one-tailed Student’s t test. TIRF Microscopy with +Cadherin Coverslips Uncoated glass-bottom chambers (Number 1.0, MatTek Corporation) were precoated with poly-L-lysine (PLL; 1 mg/ml) and allowed to dry overnight in a sterile hood. The amino groups on the PLL were then activated for 90 min with 2.5% gluteraldehyde in 50 mM Na-phosphate buffer (pH 6.8), washed several times, and exposed to Cy5-tagged anti-human Fc secondary antibody (diluted 1:10 in 100 mM sodium carbonate, pH 9.4; Jackson ImmunoResearch Laboratories). +Cadherin coverslips were then generated via the application of a fusion protein between human Fc and N-cadherin (diluted 1:10 in PBS; R&D Systems). −Cadherin coverslips were generated by exposure to buffer once the secondary antibody was applied. HeLa cells were plated on the coverslips and transfected with Cx43-YFP. Imaging was carried out using a Nikon TE-2000E inverted microscope with a 60× 1.45 NA TIRF objective equipped for 1.5× Optivar magnification and through-the-objective TIRF illumination using a 488 nm argon laser. TIRF imaging of Cx43-YFP in the presence of drugs and knockdown reagents as well as for GFP EB1 and of Cx43-RFP was carried out with a 100× 1.49 NA TIRF objective using either a 488 nm, 514 nm, or 543 nm argon laser. Cells were maintained in Hank’s BSS + 5% Fetal Bovine Serum (UCSF Cell Culture Facility) at 37°C. Time lapse sequences were acquired at a continuous rate of two frames per second with 200 ms of exposure per frame. Cx43-RFP imaging required 400 ms of exposure per frame with capture at the same frame rate. Automated quantification of vesicle fusion events was achieved by first performing a temporal average of the last minute of images acquired during a 5 min acquisition. This technique enriched for fixed over mobile vesicles. A minimum intensity threshold of 300 AU/pixel was applied to remove background signal (same threshold for each cell), and vesicles were counted by selecting for particles between 400 nm and 1000 nm in diameter. All TIRF image processing was performed with ImageJ software (NIH). Preparation of Isolated Cardiomyocytes Rat ventricular myocytes were isolated from adult Sprague Dawley rats (200 to 300 g; Charles River) after dissociation with collagenase type 2 (Worthington, Lakewood, NJ) with previously described methods (Hu et al., 2003). Attachment to coverslips, fixation, and immunostaining followed the same protocols as those used for HeLa cells (above). Supplemental Text Click here to view.(3.2M, pdf) Supplemental Movie 1 Click here to view.(45M, avi) Supplemental Movie 2 Click here to view.(4.6M, avi) Supplemental Movie 3 Click here to view.(4.8M, avi) Supplemental Movie 4 Click here to view.(43M, avi) Supplemental Movie 5 Click here to view.(57M, avi) Acknowledgments We are grateful to Dr. Dale Laird (Ontario) for the Cx43-YFP and the Cx26-YFP constructs, Dr. James Trosko (Michigan State) for the WB-F344 hepatic epithelial cell line, Dr. Bert Vogelstein (Johns Hopkins) for the GFP-EB1 construct, Dr. Xiang Qian (Jan Lab) for technical assistance with cardiomyocytes, and other members of the Jan Lab for comments on this manuscript. This work was supported by National Institutes of Health Grants NIMH 065334 (L.Y.J.), NIDA 10711 and 10154 (M.v.Z.), NHLBI 075449 (R.M.S.), and American Heart Association Grant 0475022N (R.M.S.). Y.-N.J. and L.Y.J. are Howard Hughes Medical Institute Investigators. Footnotes Supplemental Data Supplemental Data include 13 figures, five movies, Supplemental Experimental Procedures, and Supplemental References and can be found with this article online at http://www.cell.com/cgi/content/full/128/3/547/DC1/. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Bioessays. 1996 Sep; 18(9):719-30.
[Bioessays. 1996]Circ Res. 1997 Nov; 81(5):727-41.
[Circ Res. 1997]Circulation. 1998 Feb 24; 97(7):651-60.
[Circulation. 1998]Circulation. 1997 Feb 18; 95(4):988-96.
[Circulation. 1997]Circ Res. 2005 Jul 22; 97(2):159-67.
[Circ Res. 2005]Circ Res. 1998 Sep 21; 83(6):629-35.
[Circ Res. 1998]Biochem J. 1991 Jan 1; 273(Pt 1)():67-72.
[Biochem J. 1991]Mol Biol Cell. 1999 Jun; 10(6):2033-50.
[Mol Biol Cell. 1999]Proc Natl Acad Sci U S A. 2002 Aug 6; 99(16):10446-51.
[Proc Natl Acad Sci U S A. 2002]Science. 2002 Apr 19; 296(5567):503-7.
[Science. 2002]Curr Biol. 1998 Jul 30-Aug 13; 8(16):931-4.
[Curr Biol. 1998]Circ Res. 1997 Jan; 80(1):88-94.
[Circ Res. 1997]Circ Res. 1999 Nov 26; 85(11):1046-55.
[Circ Res. 1999]Proc Natl Acad Sci U S A. 1988 Oct; 85(19):7274-8.
[Proc Natl Acad Sci U S A. 1988]J Cell Sci. 2003 Apr 15; 116(Pt 8):1471-9.
[J Cell Sci. 2003]Nat Cell Biol. 2002 Apr; 4(4):E101-8.
[Nat Cell Biol. 2002]Curr Opin Cell Biol. 2005 Feb; 17(1):47-54.
[Curr Opin Cell Biol. 2005]J Cell Biol. 2005 Jan 3; 168(1):141-53.
[J Cell Biol. 2005]Curr Biol. 1999 Apr 22; 9(8):425-8.
[Curr Biol. 1999]Nat Cell Biol. 2000 Nov; 2(11):797-804.
[Nat Cell Biol. 2000]Oncogene. 1998 Dec 31; 17(26):3471-7.
[Oncogene. 1998]Mol Biol Cell. 1999 Jun; 10(6):2033-50.
[Mol Biol Cell. 1999]Curr Opin Cell Biol. 1998 Feb; 10(1):60-73.
[Curr Opin Cell Biol. 1998]Oncogene. 1998 Dec 31; 17(26):3471-7.
[Oncogene. 1998]Nat Cell Biol. 2000 Nov; 2(11):797-804.
[Nat Cell Biol. 2000]Mol Biol Cell. 2000 Jul; 11(7):2471-83.
[Mol Biol Cell. 2000]Nat Cell Biol. 2001 Oct; 3(10):913-7.
[Nat Cell Biol. 2001]Genes Dev. 2001 Jan 1; 15(1):1-14.
[Genes Dev. 2001]Mol Biol Cell. 2002 Oct; 13(10):3627-45.
[Mol Biol Cell. 2002]Curr Opin Cell Biol. 2002 Feb; 14(1):44-9.
[Curr Opin Cell Biol. 2002]Trends Cell Biol. 2004 Nov; 14(11):612-9.
[Trends Cell Biol. 2004]Dev Biol. 1996 Oct 10; 179(1):1-16.
[Dev Biol. 1996]J Cell Sci. 2001 Mar; 114(Pt 6):1155-67.
[J Cell Sci. 2001]Mol Biol Cell. 1999 Jun; 10(6):2033-50.
[Mol Biol Cell. 1999]Proc Natl Acad Sci U S A. 2002 Aug 6; 99(16):10446-51.
[Proc Natl Acad Sci U S A. 2002]Science. 2002 Apr 19; 296(5567):503-7.
[Science. 2002]Proc Natl Acad Sci U S A. 2002 Aug 6; 99(16):10446-51.
[Proc Natl Acad Sci U S A. 2002]Biochim Biophys Acta. 2005 Jun 10; 1711(2):172-82.
[Biochim Biophys Acta. 2005]Proc Natl Acad Sci U S A. 2002 Aug 6; 99(16):10446-51.
[Proc Natl Acad Sci U S A. 2002]J Cell Sci. 2005 Oct 1; 118(Pt 19):4451-62.
[J Cell Sci. 2005]Exp Cell Res. 1984 Dec; 155(2):406-12.
[Exp Cell Res. 1984]Curr Opin Cell Biol. 1990 Oct; 2(5):875-80.
[Curr Opin Cell Biol. 1990]Annu Rev Biochem. 1990; 59():237-52.
[Annu Rev Biochem. 1990]J Cell Biol. 2003 Sep 15; 162(6):1045-55.
[J Cell Biol. 2003]J Cell Sci. 2001 Jan; 114(Pt 2):247-55.
[J Cell Sci. 2001]Mol Biol Cell. 2002 Oct; 13(10):3627-45.
[Mol Biol Cell. 2002]Mol Cell. 2005 Aug 19; 19(4):449-60.
[Mol Cell. 2005]Nat Cell Biol. 2001 Oct; 3(10):913-7.
[Nat Cell Biol. 2001]Cell. 2005 Dec 2; 123(5):903-15.
[Cell. 2005]J Biol Chem. 2001 Sep 7; 276(36):33305-8.
[J Biol Chem. 2001]Annu Rev Cell Dev Biol. 2003; 19():207-35.
[Annu Rev Cell Dev Biol. 2003]Annu Rev Cell Dev Biol. 2004; 20():811-38.
[Annu Rev Cell Dev Biol. 2004]Physiol Rev. 2003 Apr; 83(2):337-76.
[Physiol Rev. 2003]Biol Cell. 2002 Nov; 94(7-8):493-500.
[Biol Cell. 2002]Semin Cancer Biol. 2002 Aug; 12(4):267-76.
[Semin Cancer Biol. 2002]BMC Cell Biol. 2005 Feb 16; 6(1):7.
[BMC Cell Biol. 2005]Circ Res. 1999 Nov 26; 85(11):1046-55.
[Circ Res. 1999]Mol Cell Neurosci. 2000 May; 15(5):456-64.
[Mol Cell Neurosci. 2000]Neuron. 2003 May 8; 38(3):417-32.
[Neuron. 2003]